Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sestrin-3 (SESN3) is a member of the sestrin family of stress-induced proteins that regulates cellular responses to oxidative and genotoxic stress by decreasing intracellular reactive oxygen species levels[1][4]. It plays a crucial role in maintaining glucose and lipid homeostasis, modulating insulin sensitivity, and controlling lipid storage, with particular significance in metabolic tissues such as the liver[2][4]. SESN3 acts as a metabolic regulator through negative feedback of the mTORC1 signaling pathway and positive activation of mTORC2/Akt signaling, thereby influencing cellular metabolism and stress adaptation[2][4]. It also functions in neuroinflammation, modulating pro-inflammatory cytokine expression and has been linked to neurological disorders like epilepsy[3]. No specific drugs targeting Sestrin-3 are currently available, but its central regulatory functions make it an attractive candidate for future therapeutic intervention in metabolic, inflammatory, and neurodegenerative diseases[2][3][4].
Not applicable (Direct mechanisms of action for drugs not established; SESN3 instead acts through regulation of mTORC1/2 pathways and modulation of oxidative stress[2][4])
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sestrin-3 (SESN3).